Trial Holdings Inc
141A.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.57 | 0.41 | -1.20 | -4.67 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 43.43 | 27.19 | 30.74 | 28.89 |
| Quality | ||||
| ROIC | -0.25% | 2.76% | 1.52% | 1.90% |
| Gross Margin | 24.38% | 22.26% | 20.64% | 20.21% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 12.06% | 18.34% | 33.71% | 65.21% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 24.13 | -3.69 | -4.60 | -9.61 |
| Interest Coverage | 2.45 | 477.63 | 235.25 | 238.45 |
| Efficiency | ||||
| Inventory Turnover | 3.20 | 2.81 | 2.88 | 3.02 |
| Cash Conversion Cycle | -11.48 | -13.28 | -17.55 | -37.75 |